Peter H. Griffith

Executive Vice President and Chief Financial Officer (Principal Financial Officer), Amgen

In the seat. First published here October 28, 2026; built from records as of October 28, 2026.

Peter H. Griffith signed the annual report of Amgen as Executive Vice President and Chief Financial Officer (Principal Financial Officer); the report was filed on February 13, 2026, the most recent filing in the record that ties Peter H. Griffith to the seat.¹

Seats

The seat in the record

Company	Title as filed	Standing	Filings
Amgen (AMGN) Biological Products, (No Diagnostic Substances)	Executive Vice President and Chief Financial Officer (Principal Financial Officer)	In the seat	1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

February 13, 202610-K filed
Peter H. Griffith signed the annual report of Amgen on Form 10-K as Executive Vice President and Chief Financial Officer (Principal Financial Officer), filed February 13, 2026.
/s/ PETER H. GRIFFITH Peter H. Griffith Executive Vice President and Chief Financial Officer (Principal Financial Officer)
[1] Annual report on Form 10-K by Amgen, filed with the SEC on February 13, 2026. Read the filing. The record at CFO Tribune.

Sources

Annual report on Form 10-K, Amgen. U.S. Securities and Exchange Commission, EDGAR, filed February 13, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Peter H. Griffith wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.